flumazenil has been researched along with Heart Disease, Ischemic in 2 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yao, Z | 1 |
McPherson, BC | 1 |
Liu, H | 1 |
Shao, Z | 1 |
Li, C | 1 |
Qin, Y | 1 |
Vanden Hoek, TL | 1 |
Becker, LB | 1 |
Schumacker, PT | 1 |
Dzhambov, AM | 1 |
Dimitrova, DD | 1 |
2 other studies available for flumazenil and Heart Disease, Ischemic
Article | Year |
---|---|
Signal transduction of flumazenil-induced preconditioning in myocytes.
Topics: Animals; Carbazoles; Cell Death; Chick Embryo; Cytosol; Enzyme Activation; Enzyme Inhibitors; Flumaz | 2001 |
Association between Noise Pollution and Prevalent Ischemic Heart Disease.
Topics: Adult; Aged; Bulgaria; Cross-Sectional Studies; Ethnicity; Female; Humans; Incidence; Male; Middle A | 2016 |